08 glutamater part2 4pp
DESCRIPTION
rfedTRANSCRIPT
-
Glutamate Receptors: Learning, Memory,
Excitotoxicity & Seizures
Outline
Glutamate receptors & excitotoxicity: NMDA-R antagonist as therapeutics
Glutamate receptors & Learning, memory, long-term potentiation: Can increasing the effect of glutamate enhance cognition?
Glutamate Receptors
Glutamate: major excitatory neurotransmitter in brain AMPA receptor
agonist: glutamate, AMPA, Quisqualate; Antagonist: NBQX, CNQX
Na+ & K+ permeable, low Ca2+ permeability, not blocked by Mg2+
Can be activated at all membrane potentials; fast EPSP
NMDA receptor: agonist: glutamate, aspartate, NMDA; co-agonist: glycine;
antagonist AP-5; channel blocker: PCP, ketamine, memantine Na+, K+ & highly Ca2+ permeable, blocked by Mg2+
Can be activated only at depolarized potentials; slow EPSP
Calcium
Excitotoxicity
-
NMDA Receptors & Calcium
Excitotoxicity,Seizures
LearningMemory
Seizures
DiatomRed Tide
Glutamate
Domoic Acid
Seizures,Death
Excitoxicity
Ischemic Stroke:Clot prevents blood flow,O2 & glucose to brainAlso caused by: Head injury, Hypoglycemia Repeated intense seizures
(status epilepticus)
Energy-dependent reuptake of glutamate from synaptic cleft is reduced.
Glutamate causes cytoplasmic Ca2+,neurotoxicity & cell death.
Ca2+
TOOMUCH
CALCIUM
Mechanisms of Excitotoxicity & Cell Death
Glutamate: activates AMPA R depolarizes cell membrane permits Ca2+ entry through
NMDA R & voltage-activated calcium channels
Ca2+ entry: Overloads mitochondrial and
ER mechanisms to remove cytoplasmic Ca2+
Activates proteases & lipases Creates reactive oxygen
species, free radicals, damages lipids, proteins & DNA.
-
Pharmacological Treatment for Stroke: Aspirin: reduces clot formation, inhibits platelet
thromboxane production which reduces platelet aggregation
tPA (tissue plasminogen activator): clot buster; catalyzes breakdown of plasminogen to plasmin, which proteolyzes fibrin; administered within 3 hrs of stroke
Inhibit NMDA receptor?
NMDA Receptor Blockers:
Block of Excitotoxicity: Memantine as Treatment for Alzheimers Disease
Memantine binds in pore & blocks open NMDA Receptor channel
Unlike PCP and ketamine, it has a fast off rate and lower affinity, so doesnt block normal synaptic transmission, but does block excessive glutamate stimulation.
Excitotoxicity NMDA Receptors & Calcium
Excitotoxicity,Seizures
LearningMemory
-
Morris Water Maze
Or with NMDA antagonist
Learning, Memory & Long-term potentiation: The hippocampus is a brain region involved in learning Activation of NMDA receptors is required for learning
High Frequency Stimulation Causes Long Term Potentiation (LTP)
-
Calcium
LTD:Endocytosis of AMPA receptors from plasma membrane of dendritic spines
LTP:Insertion of AMPA receptors into plasma membrane of dendritic spines
AMPA R subunit
Green fluorescent protein
High Frequency Stimulation Causes Delivery of AMPA Receptors to Dendritic Spines
High Frequency Stimulation
AMPA R delivered to spine
-
Delivery of AMPA-R to Spines is Blocked by NMDA-R Antagonist (APV) AMPA Modulators as Therapeutics: Ionotropic receptors desensitize in
continued presence of agonist
Agonist binds to desensitized receptor with higher affinity, but receptor doesnt open
AMPA modulators ampakine or aniracitam slow desensitization
Enhancement of AMPA responses enhances attention, learning & memory; a new approach for cognition enhancers (nootropic drugs)
Glutamate Glutamate
+ Ampakine
Closed Open Desensitized
desensitization
What happens downstream of calcium influx through NMDA-R to cause LTP?
Calcium activates both Ca2+/calmodulin kinase II and protein kinase C
These kinases phosphorylate substrates, including AMPA-R, which increases AMPA-R insertion into the spine plasma membrane
How can downstream signaling pathways be studied?
Measure activation of CaMKIIusing fluorescent CaMKII reporter
At the same time, apply a caged glutamate agonist, and release the glutamate with a laser flash to locally increase [glutamate] in one dendritic spine
-
Summary Glutamate: major excitatory neurotransmitter in brain AMPA receptor
agonist: glutamate, AMPA, Quisqualate; Antagonist: NBQX, CNQX Na+ & K+ permeable, low Ca2+ permeability, not blocked by Mg2+
Can be activated at all membrane potentials; fast EPSP NMDA receptor:
agonist: glutamate, aspartate, NMDA; co-agonist: glycine; antagonist AP-5; channel blocker: PCP, ketamine
Na+, K+ & highly Ca2+ permeable, blocked by Mg2+
Can be activated only at depolarized potentials; slow EPSP Excitotoxicity: ischemia or trauma leads to glutamate, Ca2+ influx & cell death
tPA to treat stroke; NMDA antagonists as therapeutic for Alzheimers & potential therapeutic for stroke, trauma
Long-term potentiation: The hippocampus is a brain region involved in learning Activation of NMDA receptors is required for learning Train of stimuli activates AMPA R which depolarizes the membrane & relieves the Mg2+ block of
NMDA R. NMDA R allow Ca 2+ influx, which initiates signaling cascades that cause long term increase in
synaptic strength Redistribution of AMPA receptors into dendritic spines underlies LTP (insertion of AMPA R) and
LTD (retrieval of AMPA R) AMPA R positive modulators as therapeutics for cognition enhancers (nootropic drugs)